E-LIB Suche - Ergebnisse für: Charbonnel, Bernard H

1

Treatment patterns and glycated haemoglobin levels over 36 ..:

Charbonnel, Bernard H. ; Chen, Hungta ; Cid‐Ruzafa, Javier...
Diabetes, Obesity and Metabolism. 25 (2022) 1 - p. 46-55 , 2022

Link: https://doi.org/10.1111/..

2

Inappropriate intensification of glucose-lowering treatment..:

Bongaerts, Brenda ; Arnold, Suzanne V ; Charbonnel, Bernard H...
BMJ Open Diabetes Research & Care. 9 (2021) 1 - p. e001585 , 2021

Link: https://doi.org/10.1136/..

3

Risk of Breast Cancer by Individual Insulin Use: An Interna..:

Grimaldi-Bensouda, Lamiae ; Cameron, David ; Marty, Michel...
Diabetes Care. 37 (2013) 1 - p. 134-143 , 2013

Link: https://doi.org/10.2337/..

4

Saxagliptin Add-on Therapy to Insulin With or Without Metfo..:

Barnett, Anthony H. ; Charbonnel, Bernard ; Li, Jia...
Clinical Drug Investigation. 33 (2013) 10 - p. 707-717 , 2013

Link: https://doi.org/10.1007/..

5

Long-Term Lipid Effects of Pioglitazone by Baseline Anti-Hy..:

Spanheimer, Robert ; Betteridge, D. John ; Tan, Meng H...
The American Journal of Cardiology. 104 (2009) 2 - p. 234-239 , 2009

Link: https://doi.org/10.1016/..

6

Photocatalytic abatement results from a model street canyon:

Gallus, M. ; Ciuraru, R. ; Mothes, F....
Environmental Science and Pollution Research. 22 (2015) 22 - p. 18185-18196 , 2015

Link: https://doi.org/10.1007/..

7

Long-term therapy with addition of pioglitazone to metformi..:

Matthews, D. R. ; Charbonnel, B. H. ; Hanefeld, M...
Diabetes/Metabolism Research and Reviews. 21 (2005) 2 - p. 167-174 , 2005

Link: https://doi.org/10.1002/..

8

A long‐term comparison of pioglitazone and gliclazide in pa..:

Charbonnel, B. H. ; Matthews, D. R. ; Schernthaner, G....
Diabetic Medicine. 22 (2005) 4 - p. 399-405 , 2005

Link: https://doi.org/10.1111/..

9

Ertugliflozin, renoprotection and potential confounding by ..:

Cherney, David Z. I. ; Charbonnel, Bernard ; Cosentino, Francesco...
Diabetologia. 65 (2022) 5 - p. 908-911 , 2022

Link: https://doi.org/10.1007/..

10

Type 2 diabetes and heart failure: insights from the global..:

Arnold, Suzanne V. ; Khunti, Kamlesh ; Bonnet, Fabrice...
ESC Heart Failure. 8 (2021) 2 - p. 1711-1716 , 2021

Link: https://doi.org/10.1002/..

11

Prevalence and progression of chronic kidney disease among ..:

Khunti, Kamlesh ; Charbonnel, Bernard ; Chen, Hungta...
Diabetes, Obesity and Metabolism. 23 (2021) 8 - p. 1956-1960 , 2021

Link: https://doi.org/10.1111/..

12

Associations between second‐line glucose‐lowering combinati..:

Khunti, Kamlesh ; Charbonnel, Bernard ; Cooper, Andrew...
Diabetes, Obesity and Metabolism. 23 (2021) 8 - p. 1823-1833 , 2021

Link: https://doi.org/10.1111/..

13

Effects of ertugliflozin on kidney composite outcomes, rena..:

on behalf of the VERTIS CV Investigators ; Cherney, David Z. I. ; Charbonnel, Bernard...
Diabetologia. 64 (2021) 6 - p. 1256-1267 , 2021

Link: https://doi.org/10.1007/..

14

Glycaemic control and hypoglycaemia risk with insulin glarg..:

Bolli, Geremia B. ; Cheng, Alice ; Charbonnel, Bernard...
Diabetes, Obesity and Metabolism. 23 (2021) 7 - p. 1588-1593 , 2021

Link: https://doi.org/10.1111/..

15

Efficacy and safety of ertugliflozin in older patients with..:

Pratley, Richard ; Dagogo‐Jack, Samuel ; Charbonnel, Bernard...
Diabetes, Obesity and Metabolism. 22 (2020) 12 - p. 2276-2286 , 2020

Link: https://doi.org/10.1111/..